1 enrolling by invitation, 1 withdrawn. 1 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Enrolling by invitation 1 |
| Phase 1 | 1 | Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Nandakumar Narayanan: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Terazosin And Metabolic Engagement in Parkinson's Disease Terazosin Hydrochloride, Placebo - Parkinson's Disease | Phase 1 / Phase 2 | Withdrawn | Nandakumar Narayanan | 2026-09-01 | 2026-10-07 | |
| Mid-frontal Delta/Theta and Cognitive Control Deep-brain Stimulation, Transcranial Magnetic Stimulation, Transcranial Alternating Current Stimulation - Parkinson&Amp;Amp;#39;s Disease (PD) | Not applicable | Enrolling by invitation | Nandakumar Narayanan | 635 | 2017-09-25 | 2025-05-22 |
Cognitive Dysfunction (1) · Dementia (1) · Parkinson Disease (1)
Deep Brain Stimulation (1) · Terazosin (1) · Transcranial Direct Current Stimulation (1) · Transcranial Magnetic Stimulation (1)
United States (1)
PMID 29190362, PMID 29593630, PMID 29802866, PMID 31991312, PMID 32390797, PMID 32437650, PMID 32891924, PMID 32954522, PMID 33205381, PMID 33523098, PMID 33589640, PMID 34601038, PMID 34690147, PMID 34824891, PMID 35248205, PMID 35297483, PMID 36054705, PMID 36203748, PMID 36952070, PMID 36993450, PMID 37092236, PMID 37263767, PMID 37873396, PMID 38172519, PMID 39003229
R01NS100849 (1)